机译:用UPLC / MS为基于Nontargeted和靶向分析,选择小浆肽的辅助诊断和预后的副血浆肽
Harbin Inst Technol Sch Life Sci &
Technol Harbin Heilongjiang Peoples R China;
Harbin Inst Technol Sch Life Sci &
Technol Harbin Heilongjiang Peoples R China;
Harbin Med Univ Affiliated Tumor Hosp Dept Gynecol Harbin Heilongjiang Peoples R China;
Harbin Inst Technol Sch Life Sci &
Technol Harbin Heilongjiang Peoples R China;
Harbin Inst Technol Sch Life Sci &
Technol Harbin Heilongjiang Peoples R China;
Harbin Inst Technol Sch Life Sci &
Technol Harbin Heilongjiang Peoples R China;
Harbin Med Univ Sch Publ Hlth Dept Epidemiol &
Biostat 157 Baojian Rd Harbin 150081;
Harbin Med Univ Affiliated Hosp 1 Dept Cardiol Harbin Heilongjiang Peoples R China;
Harbin Med Univ Sch Publ Hlth Dept Epidemiol &
Biostat 157 Baojian Rd Harbin 150081;
Harbin Med Univ Sch Publ Hlth Dept Epidemiol &
Biostat 157 Baojian Rd Harbin 150081;
epithelial ovarian cancer; biomarker; small peptide; metabolic profiling analysis;
机译:用UPLC / MS为基于Nontargeted和靶向分析,选择小浆肽的辅助诊断和预后的副血浆肽
机译:MiR-506抑制上皮-间充质转化网络中的多个靶标,并与上皮性卵巢癌的良好预后相关
机译:Kcnma1-AS1衰减上皮性卵巢癌细胞的凋亡,并用作上皮性卵巢癌预后不良的危险因素
机译:SOR-C13,一种靶向TRPV6 oncoChannel的新型癌症肽治疗性靶向鼠模型中的乳腺癌和卵巢癌异种移植物的疗效
机译:肽J18的修饰以增强卵巢癌细胞的靶向性
机译:上皮性卵巢癌血浆外泌体的蛋白质组学分析:在凝血级联反应诊断和预后中的潜在作用
机译:miR-506抑制上皮 - 间充质过渡网络中的多种靶标,并且在上皮性卵巢癌中具有良好的预后